Cargando…
Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey
OBJECTIVE: The outbreak of COVID-19 pandemic has greatly impacted on radiotherapy (RT) strategy for breast cancer patients, which might lead to increased distressing psychological symptoms. We performed a multi-center cross-section survey to investigate prevalence of fear of cancer recurrence (FCR)...
Autores principales: | Xie, Jinrong, Qi, Weixiang, Cao, Lu, Tan, Yuting, Huang, Jin, Gu, Xiaodong, Chen, Bingguang, Shen, Peipei, Zhao, Yutian, Zhang, Ying, Zhao, Qingwen, Huang, Hecheng, Wang, Yubin, Fang, Haicheng, Jin, Zhenjun, Li, Hui, Zhao, Xuehong, Qian, Xiaofang, Xu, Feifei, Ou, Dan, Wang, Shubei, Xu, Cheng, Li, Min, Jiang, Zefei, Wang, Yu, Huang, Xiaobo, Chen, Jiayi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351463/ https://www.ncbi.nlm.nih.gov/pubmed/34381703 http://dx.doi.org/10.3389/fonc.2021.650766 |
Ejemplares similares
-
A Novel Nomogram for Predicting Prognosis and Tailoring Local Therapy Decision for Ductal Carcinoma In Situ after Breast Conserving Surgery
por: Xu, Feifei, et al.
Publicado: (2022) -
Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial
por: Xie, Jinrong, et al.
Publicado: (2022) -
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort
por: Qi, Wei‐Xiang, et al.
Publicado: (2023) -
Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer
por: Xu, Fei, et al.
Publicado: (2023) -
Role of a multidisciplinary team in administering radiotherapy for esophageal cancer
por: Zhao, Shengguang, et al.
Publicado: (2020)